You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Sjogren's syndrome
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:diseases:sjogrens [01.02.2019] – sallieqhome:diseases:sjogrens [01.03.2019] – [Traditional Chinese medicines used in primary Sjogren's syndrome patients] sallieq
Line 27: Line 27:
 This information aids understanding of the history and development of dry eye research, in addition to the impact and characteristics of the contributors to the field.  (({{pubmed>long:23321358}}))   This information aids understanding of the history and development of dry eye research, in addition to the impact and characteristics of the contributors to the field.  (({{pubmed>long:23321358}}))  
  
 +The purpose of this study was to investigate salivary tissue assessment with various sonoelastographic modalities (real-time tissue elastography, Virtual Touch imaging and quantification) in patients with Sjögren's syndrome as compared with an appropriate control group. (({{pubmed>long:27207020}}))  
  
 Primary Sjögren's syndrome (pSS) is a chronic systemic autoimmune disease, of slow progression, characterized by lymphocytic infiltration of the exocrine glands, that leads to sicca symptoms, mainly xerophtalmia and xerostomia. It may involve any organ and lead to extraglandular manifestations, which also can precede typical glandular manifestations and delay the diagnosis of pSS. In the past years, better knowledge of the disease has led to improvement in treatment management.  (({{pubmed>long:21794757}}))   Primary Sjögren's syndrome (pSS) is a chronic systemic autoimmune disease, of slow progression, characterized by lymphocytic infiltration of the exocrine glands, that leads to sicca symptoms, mainly xerophtalmia and xerostomia. It may involve any organ and lead to extraglandular manifestations, which also can precede typical glandular manifestations and delay the diagnosis of pSS. In the past years, better knowledge of the disease has led to improvement in treatment management.  (({{pubmed>long:21794757}}))  
Line 119: Line 120:
  
  
-{{tag>disease arrange}}+{{tag>disease }}
  
  
home/diseases/sjogrens.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.